China Retaliates Against European Union Device Manufacturers

Imposes a ban on European medical devices

Growing China-EU Trade Conflict

The medical device industry is now the latest battleground in a growing China-EU trade conflict – with potential ripple effects across global supply chains and health procurement markets.

The AP reports that in an escalating trade dispute, China has barred European medical device companies from participating in government procurement contracts over 45 million yuan ($6.28 million). The ban, announced Sunday by China’s Finance Ministry, took effect immediately and is seen as retaliation for European Union trade restrictions on Chinese products.

Key Details:

  • The ban applies only to non-Chinese-manufactured EU products.
  • EU firms that produce within China are exempt.
  • It mirrors a June EU policy excluding Chinese companies from public procurement over €5 million.

Broader EU-China Trade Tensions

  • On Friday, China imposed anti-dumping duties on European brandy, particularly affecting French cognac.
  • China is also investigating EU pork and dairy imports following EU actions targeting Chinese electric vehicles (EVs).
  • The EU claims China’s procurement process discriminates against foreign firms, citing legal and administrative barriers.

China’s Response

China’s Ministry of Commerce said it had shown goodwill and willingness to negotiate but accused the EU of ignoring diplomatic overtures and erecting new protectionist barriers.

Read more here. 

News

FDA Enforcement

Safety Alerts

Medical Devices

Pharma

New Drugs

Drug Shortages

Medline Recalls Angiographic RA Control Syringes

Angiographic Syringe Recall: Medline Removes RA Control Syringes Due to Risk of Disconnection and Air Embolism The U.S. Food and Drug Administration (FDA) has announced that Medline Industries has issued an Urgent Medical Device Recall involving certain Namic...

FDA Class I Recall for Abiomed Impella Gen 1 Purge Cassettes

Medical Device Alert: Abiomed Impella Purge Cassette Recall (Class I) Abiomed has initiated a Class I recall, the most serious classification issued by the U.S. Food and Drug Administration, for certain Impella purge cassettes and associated pump sets due to a...

Class I Correction for Abiomed Impella Inaccurate Flow Readings

Abiomed Impella RP: FDA Class I Correction for Inaccurate Flow Readings Abiomed has issued an Urgent Medical Device Correction for its Impella RP with SmartAssist and Impella RP Flex with SmartAssist systems due to potential inaccuracies in displayed pump performance...